SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-000879
Filing Date
2023-02-14
Accepted
2023-02-14 16:16:33
Documents
56
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_i10q-123122.htm   iXBRL 10-Q 756151
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_ex3101.htm EX-31.1 8519
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_ex3102.htm EX-31.2 8393
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4474
  Complete submission text file 0001683168-23-000879.txt   3736770

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20221231.xsd EX-101.SCH 26564
6 XBRL CALCULATION FILE snoa-20221231_cal.xml EX-101.CAL 49247
7 XBRL DEFINITION FILE snoa-20221231_def.xml EX-101.DEF 95895
8 XBRL LABEL FILE snoa-20221231_lab.xml EX-101.LAB 243584
9 XBRL PRESENTATION FILE snoa-20221231_pre.xml EX-101.PRE 197509
50 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-123122_htm.xml XML 512667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 23629564
SIC: 2834 Pharmaceutical Preparations